发明申请
- 专利标题： OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES
- 专利标题（中）： 用于治疗糖尿病的氧化亚砷酸化合物
-
申请号： US12849225申请日： 2010-08-03
-
公开(公告)号： US20110039837A1公开(公告)日： 2011-02-17
- 发明人: Adnan M.M. Mjalli , Dharma Rao Polisetti , Thomas Scott Yokum , Kalpathy Santhosh , Mustafa Guzel , Christopher Behme , Stephen Thomas Davis
- 申请人： Adnan M.M. Mjalli , Dharma Rao Polisetti , Thomas Scott Yokum , Kalpathy Santhosh , Mustafa Guzel , Christopher Behme , Stephen Thomas Davis
- 申请人地址： US NC High Point
- 专利权人： TRANSTECH PHARMA, INC.
- 当前专利权人： TRANSTECH PHARMA, INC.
- 当前专利权人地址： US NC High Point
- 主分类号： A61K31/5383
- IPC分类号： A61K31/5383 ; A61P3/04
摘要：
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, R, R1, R2, R3, R4 and R5 are as herein described, and wherein said methods of use include uses for the treatment and/or prevention of disorders and diseases, such as diabetes.
公开/授权文献
- US07906507B2 Oxadiazoanthracene compounds for the treatment of diabetes 公开/授权日：2011-03-15